{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:04:20Z","timestamp":1789779860857,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jjcc.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T09:47:19Z","timestamp":1425289639000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease"],"prefix":"10.1016","volume":"66","author":[{"given":"Tomoya","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2015.02.002_bib0275","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2013 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0285","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hanson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0290","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0295","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0300","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implication for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0305","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0310","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0315","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ahj.2013.03.018","article-title":"Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis","volume":"166","author":"Everett","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0320","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of proinflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0330","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.ATV.16.8.1013","article-title":"Lymphocyte populations in atherosclerotic lesions of apoE\u2212\/\u2212 and LDL receptor\u2212\/\u2212 mice. Decreasing density with disease progression","volume":"16","author":"Roselaar","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0335","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0340","doi-asserted-by":"crossref","first-page":"723539","DOI":"10.1155\/2008\/723539","article-title":"Antigen-induced immunomodulation in the pathogenesis of atherosclerosis","volume":"2008","author":"Milioti","year":"2008","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0345","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.293.21.2641","article-title":"Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials","volume":"293","author":"Andraws","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0350","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1073\/pnas.92.3.821","article-title":"Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis","volume":"92","author":"Palinski","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0355","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.ATV.18.12.1972","article-title":"Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes","volume":"18","author":"Freigang","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0360","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","article-title":"B cells and humoral immunity in atherosclerosis","volume":"114","author":"Tsiantoulas","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0365","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.ATV.0000067937.93716.DB","article-title":"Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences","volume":"23","author":"Fredrikson","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0370","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/MOL.0b013e328356ec7c","article-title":"Apolipoprotein B100 autoimmunity and atherosclerosis \u2013 disease mechanisms and therapeutic potential","volume":"23","author":"Nilsson","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/01.ATV.21.1.108","article-title":"LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis","volume":"21","author":"Zhou","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0380","doi-asserted-by":"crossref","first-page":"C865","DOI":"10.1152\/ajpcell.00117.2007","article-title":"Xenogenic macrophage immunization reduces atherosclerosis in apolipoprotein E knockout mice","volume":"293","author":"Yamashita","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.ATV.12.7.789","article-title":"Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65","volume":"12","author":"Xu","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0390","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2009.05.007","article-title":"Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms","volume":"125","author":"Xiong","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0395","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/01.CIR.0000029750.99462.30","article-title":"Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice","volume":"106","author":"Maron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0400","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.jacc.2014.10.018","article-title":"Vaccine for atherosclerosis","volume":"64","author":"Shah","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0405","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0410","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.106.633263","article-title":"Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule","volume":"114","author":"Gotsman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0415","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0420","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI63891","article-title":"Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis","volume":"123","author":"Klingenberg","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0425","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0430","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0435","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.109.863431","article-title":"Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice","volume":"120","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0440","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1253\/circj.CJ-14-0644","article-title":"Regulatory\/effector T-cell ratio is reduced in coronary artery disease","volume":"78","author":"Emoto","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0445","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5551\/jat.10934","article-title":"Regulatory T cells in atherogenesis","volume":"19","author":"Sasaki","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0450","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20082824","article-title":"In vivo expansion of T reg cells with IL-2\u2013mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0455","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.112.099044","article-title":"Cytokine therapy with interleukin-2\/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis","volume":"126","author":"Dinh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0460","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.114.04934","article-title":"Foxp3+ regulatory T cells play a protective role in angiotensin II-induced aortic aneurysm formation in mice","author":"Yodoi","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0465","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus","volume":"346","author":"Herold","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0470","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nri2134","article-title":"CD3-specific antibodies: a portal to the treatment of autoimmunity","volume":"7","author":"Chatenoud","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0475","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.106.627430","article-title":"Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice","volume":"114","author":"Steffens","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0480","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nm924","article-title":"TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes","volume":"9","author":"Belghith","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0485","doi-asserted-by":"crossref","first-page":"e000719","DOI":"10.1161\/JAHA.113.000719","article-title":"CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response","volume":"3","author":"Kasahara","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0490","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/ATVBAHA.111.229443","article-title":"Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor deficient mice","volume":"31","author":"Nakajima","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0495","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cvr\/cvu002","article-title":"Regression of atherosclerosis anti-CD3 antibody via augmenting a regulatory T cell response in mice","volume":"102","author":"Kita","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0500","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","article-title":"Oral tolerance","volume":"241","author":"Weiner","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0505","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.it.2008.09.002","article-title":"Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells","volume":"29","author":"Tsuji","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0510","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0515","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm1408","article-title":"Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25\u2212LAP+ T cells","volume":"12","author":"Ochi","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0520","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2337\/db06-1632","article-title":"Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody","volume":"56","author":"Ishikawa","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0525","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0530","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/ATVBAHA.110.215459","article-title":"Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions","volume":"30","author":"Takeda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0535","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.110.973222","article-title":"Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice","volume":"123","author":"Hermansson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2015.02.002_bib0540","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000330786","article-title":"Bacterial heat shock protein 60, GroEL, can induce the conversion of na\u00efve T cells into a CD4 CD25(+) Foxp3-expressing phenotype","volume":"3","author":"Ohue","year":"2011","journal-title":"J Innate Immun"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508715000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508715000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:53:59Z","timestamp":1760273639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508715000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0914508715000362"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2015.02.002","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}